Recent

% | $
Quotes you view appear here for quick access.

Sangamo Biosciences Inc. Message Board

  • mr_sundry mr_sundry Aug 1, 2011 10:28 AM Flag

    5.65 bottom proves not so

    Good evening mr_sundry has asked this content be added to your forum.

    he suggests it is clearer for many to understand why he is unwilling to buy at levels below $5.65. sundry reminds you that 8M+ share short sellers are not here for effect but simply playing odds in front of highly predictable events. Sundry suggests you examine the twice monthly short data for 18 months rolling.

    sundry insists shorts will test will of longs by applying pressure ahead of clinical data leveraging all their respective tools to do so. Risk of surprise partnership or acquisition is less than 1/20 chance. Similar odds in biotech industry for primary stat sig phase 2 double blind 1to1 placebo data.

    sundry expects many investors not suited for such level of risk some leveraged will be forced to sell if pps drops below $4.99 as will certain fund managers. Such forced selling in absence of demand will represent an opportunity for shorts to profit handsomely and cover cheap below $4.50 in q3. investors afforded vast liquidity will also take advantage.

    sundry expects internet writers to begin reporting best case 50/50 odds and risk adverse market players may choose not gamble on 1/20 or coin toss and take chips from table to play elsewhere.

    sundry continues to observe institution computer desk walk pps at will with phantom bids. Exec management team is playing their card too. Game of chicken with luxury of secondary money raised at $7.50 or higher for third time in four years. CEO slow play strategy one card at a time and tests time limit of all parties involved. CEO believes such slow play is to his advantage and will continue to compensate himself and exec team for such pace.

    sundry maintains sum of parts market cap valuation 550M and insists company cannot be purchased for such a figure and rather seeks that exact amount for 509 compound.

    As 5.65 bottom proves not so, sundry has removed his bid for common shares.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • mr_sundry, people who play russian roulette are right five our of six times. good luck. and if anything goes wrong with your stratedgy, can I have your pistol? I will sell it to a pawn shop and buy ten more shares of SGMO

      • 1 Reply to daviddavid77
      • Good evening mr_sundry has asked this content be added to your forum.

        he is very busy cutting grass and doing odd jobs around town. it is clearer for many to understand why he is willing to do whatever it takes to buy SGMO at levels below $10.00. sundry reminds you to do the same. Buyers are not here for effect but simply playing odds in front of highly predictable events. Sundry suggests you BUY, BUY, BUY!

        "This is for humor only"

    • Somewhere between wishful thinking and Crock of Shi......

    • I think this stock is oversold under $5:

      - If you walk a stock down you eventually have to walk it back up.
      - 509 is a blockbuster size opportunity – more often than not day traders and speculators are going to move in ahead of this type data release as we get closer to the 4th quarter
      - I think shorts are attracted to the lack of a catalyst over the Summer rather than shorting the release of data – that situation flips-flops in a couple months
      - How much risk is there if you can get this for $4.50 to $5? Forget about 509 results – I contend you can get in here and be out of this stock at $6 or higher before the results are ever released….not every trade has to be a 10-bagger….
      - From now to 509/528 data release there is little chance of bad news (dilution just occurred) but there is plenty of room for positive news, i.e. the hemophelia info we had not long ago….proof of concept is over, it works! It works in mice, it works in pigs, it works in plants, it works in humans

      GLTA

      • 1 Reply to ezndat
      • Sundry, we're back over $5.65....you going to buy now?

        told you to buy under $5 and now I'll tell you to buy under $6...better hurry though as under $6 is slipping away fast.

        slack coming out of the rope, speculators starting to come in ahead of ICAAC and my guess is that the %short has been decreasing...

        Several catalysts ahead and very, very intreaguing wording in the ICAAC abstracts.

        could still be some bumps in the road and the macro picture is shaky but just hunker down this Fall/Winter and my guess is Spring 2012 will be a pleasant one!

 
SGMO
4.92-0.54(-9.89%)Feb 10 4:00 PMEST